Evernest Financial Advisors LLC Sells 107 Shares of Danaher Co. (NYSE:DHR)

Evernest Financial Advisors LLC reduced its position in Danaher Co. (NYSE:DHR) by 2.2% in the 4th quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The institutional investor owned 4,746 shares of the conglomerate’s stock after selling 107 shares during the quarter. Evernest Financial Advisors LLC’s holdings in Danaher were worth $1,089,000 as of its most recent SEC filing.

Other hedge funds also recently added to or reduced their stakes in the company. Boomfish Wealth Group LLC lifted its position in shares of Danaher by 14.3% in the 4th quarter. Boomfish Wealth Group LLC now owns 3,743 shares of the conglomerate’s stock worth $859,000 after purchasing an additional 468 shares during the period. Norris Perne & French LLP MI raised its stake in Danaher by 58.8% in the fourth quarter. Norris Perne & French LLP MI now owns 130,356 shares of the conglomerate’s stock worth $29,923,000 after buying an additional 48,261 shares in the last quarter. Strategic Wealth Investment Group LLC lifted its holdings in Danaher by 11.5% during the fourth quarter. Strategic Wealth Investment Group LLC now owns 41,176 shares of the conglomerate’s stock worth $9,452,000 after buying an additional 4,263 shares during the period. Gilbert & Cook Inc. boosted its position in Danaher by 2.5% during the 4th quarter. Gilbert & Cook Inc. now owns 1,749 shares of the conglomerate’s stock valued at $401,000 after acquiring an additional 42 shares in the last quarter. Finally, Crews Bank & Trust purchased a new position in shares of Danaher in the 4th quarter valued at $551,000. 79.05% of the stock is owned by hedge funds and other institutional investors.

Analysts Set New Price Targets

DHR has been the subject of a number of recent research reports. StockNews.com downgraded shares of Danaher from a “buy” rating to a “hold” rating in a report on Saturday, December 14th. JPMorgan Chase & Co. decreased their target price on shares of Danaher from $310.00 to $300.00 and set an “overweight” rating for the company in a research report on Tuesday. Barclays cut their price target on shares of Danaher from $275.00 to $240.00 and set an “equal weight” rating on the stock in a report on Thursday. Stephens reiterated an “overweight” rating and set a $315.00 price objective on shares of Danaher in a report on Wednesday, October 23rd. Finally, TD Cowen boosted their target price on Danaher from $310.00 to $315.00 and gave the stock a “buy” rating in a research note on Wednesday, October 23rd. Six investment analysts have rated the stock with a hold rating and sixteen have assigned a buy rating to the company’s stock. According to data from MarketBeat.com, the company currently has a consensus rating of “Moderate Buy” and a consensus price target of $278.00.

Danaher Stock Performance

NYSE DHR opened at $223.16 on Friday. The firm has a market capitalization of $161.19 billion, a P/E ratio of 42.27, a PEG ratio of 4.22 and a beta of 0.83. The stock has a 50-day simple moving average of $235.89 and a two-hundred day simple moving average of $253.45. The company has a debt-to-equity ratio of 0.32, a quick ratio of 1.01 and a current ratio of 1.37. Danaher Co. has a fifty-two week low of $221.34 and a fifty-two week high of $281.70.

Danaher (NYSE:DHR) last announced its quarterly earnings results on Wednesday, January 29th. The conglomerate reported $2.14 earnings per share for the quarter, meeting the consensus estimate of $2.14. Danaher had a return on equity of 10.72% and a net margin of 16.33%. During the same quarter in the previous year, the company earned $2.09 earnings per share. On average, equities analysts forecast that Danaher Co. will post 8.15 earnings per share for the current year.

Danaher Dividend Announcement

The company also recently declared a quarterly dividend, which will be paid on Friday, January 31st. Investors of record on Friday, December 27th will be given a dividend of $0.27 per share. The ex-dividend date is Friday, December 27th. This represents a $1.08 annualized dividend and a yield of 0.48%. Danaher’s dividend payout ratio is presently 20.45%.

About Danaher

Danaher Corporation designs, manufactures, and markets professional, medical, industrial, and commercial products and services worldwide. The Biotechnology segments offers bioprocess technologies, consumables, and services that advance, accelerate, and integrate the development and manufacture of therapeutics; cell line and cell culture media development services; cell culture media, process liquids and buffers for manufacturing, chromatography resins, filtration technologies, aseptic fill finish; single-use hardware and consumables and services, such as the design and installation of full manufacturing suites; lab filtration, separation, and purification; lab-scale protein purification and analytical tools; reagents, membranes, and services; and healthcare filtration solutions.